Furosemide and Coarctation Surgery Lung Complications

Phase 2

Completed

• Conditions: Pulmonary Complication
• Interventions: Drug: Furosemide

• Registration Number: NCT03364842
• Lead Sponsor: Cairo University

Brief Summary

in our study the investigators give furosemide during surgery for repair of aortic coarctation via lateral thoracotomy and evaluated lung complications in comparison to control group

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-11-21
• Study Start: 2017-11-22
• Status Verified: 2017-12
• Study First Submitted QC: 2017-12-01
• Study First Posted: 2017-12-07
• Primary Completion: 2017-12-20
• Study Completion: 2017-12-20
• Last Update Submitted: 2017-12-22
• Last Update Posted: 2017-12-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

• coarctation of aorta

Exclusion Criteria

• heart failure, bleeding diathesis, associated cardiac congenital anomalies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
F group	Furosemide	Furosemide group

Primary Outcome Measures

Name	Time	Method
lung ultrasonography scale > 24	a 1 year study

Secondary Outcome Measures

Name	Time	Method
Pao2/ Fio2 ratio	a 1 year study

Trial Locations

Locations (1)

Cairo university; 🇪🇬 Cairo, Egypt